Legend Biotech (LEGN) Change in Inventory (2020 - 2025)
Legend Biotech (LEGN) posted Change in Inventory of $5.4 million for Q3 2025, up 292.72% on a QoQ basis from -$2.8 million in Q2 2025, and up 205.75% year-over-year from $1.8 million in Q3 2024.
Legend Biotech (LEGN) Change in Inventory (2020 - 2025) Analysis & Trends
Legend Biotech's Change in Inventory history runs 6 years deep, the most recent figure standing at $5.4 million for Q3 2025.
- Quarterly Change in Inventory rose 205.75% year-over-year to $5.4 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was -$6.9 million (up 52.8% YoY) and the FY2024 annual result came in at -$17.2 million, down 35.43% from the prior year.
- Change in Inventory was $5.4 million for Q3 2025 at Legend Biotech, up from -$2.8 million in the prior quarter.
- Across five years, Change in Inventory topped out at $5.4 million in Q3 2025 and bottomed at -$8.6 million in Q4 2022.
- A 5-year average of -$2.5 million and a median of -$2.8 million in 2025 frame the typical range for Change in Inventory.
- Annual changes were most pronounced in 2022 — Change in Inventory sank 7382.61% — and 2025, when it surged 205.75%.
- Legend Biotech's Change in Inventory stood at -$115000.0 in 2021, then sank by 7382.61% to -$8.6 million in 2022, then surged by 56.98% to -$3.7 million in 2023, then sank by 69.23% to -$6.3 million in 2024, then surged by 185.76% to $5.4 million in 2025.
- Business Quant data shows LEGN's Change in Inventory at $5.4 million in Q3 2025, -$2.8 million in Q2 2025, and -$3.2 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 71.84 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 97.70 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -26.60 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Legend Biotech | 8.26 Bn | 7.36 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 5.37 Mn |
| Sep 30, 2025 | 5.37 Mn |
| Jun 30, 2025 | -2.79 Mn |
| Jun 30, 2025 | -2.79 Mn |
| Mar 31, 2025 | -3.23 Mn |
| Mar 31, 2025 | -3.23 Mn |
| Dec 31, 2024 | -6.27 Mn |
| Dec 31, 2024 | -6.27 Mn |
| Sep 30, 2024 | -5.08 Mn |
| Sep 30, 2024 | -5.08 Mn |
| Jun 30, 2024 | -1.39 Mn |
| Jun 30, 2024 | -1.39 Mn |
| Mar 31, 2024 | -4.47 Mn |
| Mar 31, 2024 | -4.47 Mn |
| Dec 31, 2023 | -3.70 Mn |
| Dec 31, 2023 | -3.70 Mn |
| Sep 30, 2023 | -3.59 Mn |
| Sep 30, 2023 | -3.59 Mn |
| Jun 30, 2023 | -3.25 Mn |
| Jun 30, 2023 | -3.25 Mn |